BAAM
WST icon

Baker Avenue Asset Management’s West Pharmaceutical WST Stock Holding History

Baker Avenue Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$545K Buy
+1,517
New +$464K 0.01% 469
2023
Q4 		– Sell
-2,321
Closed -$871K – 1517
2023
Q3 		$871K Buy
2,321
+104
+5% +$40.2K 0.04% 212
2023
Q2 		$848K Buy
2,217
+117
+6% +$41.8K 0.04% 198
2023
Q1 		$728K Buy
2,100
+1,808
+619% +$528K 0.04% 211
2022
Q4 		$68.7K Buy
+292
New +$69.2K ﹤0.01% 452

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Baker Avenue Asset Management's WST Position: Q2 2026 in Review

Baker Avenue Asset Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,517 shares worth $545K. The stake represents 0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: Baker Avenue Asset Management previously reported a position in WST as recently as Q3 2023.

Baker Avenue Asset Management first reported a position in WST in Q4 2022 and has held it in 5 quarters since. The position peaked at $871K in Q3 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Baker Avenue Asset Management held 1,517 shares of West Pharmaceutical worth $545K as of Q2 2026.
  • West Pharmaceutical was a new Baker Avenue Asset Management position in Q2 2026.
  • West Pharmaceutical made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #469 holding.
  • Baker Avenue Asset Management first reported a position in West Pharmaceutical in Q4 2022 and has held it in 5 quarters since.
  • Baker Avenue Asset Management's West Pharmaceutical position peaked at $871K in Q3 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.